599
Views
31
CrossRef citations to date
0
Altmetric
Reviews

Endoglin for tumor imaging and targeted cancer therapy

, & , PhD
Pages 421-435 | Published online: 17 Jan 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Claudia Ollauri-Ibáñez, José M López-Novoa & Miguel Pericacho. (2017) Endoglin-based biological therapy in the treatment of angiogenesis-dependent pathologies. Expert Opinion on Biological Therapy 17:9, pages 1053-1063.
Read now
Lukas JAC Hawinkels, Amaya Garcia de Vinuesa & Peter ten Dijke. (2013) Activin receptor-like kinase 1 as a target for anti-angiogenesis therapy. Expert Opinion on Investigational Drugs 22:11, pages 1371-1383.
Read now

Articles from other publishers (29)

Geyi Zhang, Jinsheng Huang, Shuang Hao, Jingchao Zhang & Nan Zhou. (2022) Radix Astragalus Polysaccharide Accelerates Angiogenesis by Activating AKT/eNOS to Promote Nerve Regeneration and Functional Recovery. Frontiers in Pharmacology 13.
Crossref
Yi-Fan Chou, Yu-Hsuan Lan, Jun-Han Hsiao, Chiao-Yun Chen, Pei-Yu Chou & Ming-Jyh Sheu. (2022) Curcuminoids Inhibit Angiogenic Behaviors of Human Umbilical Vein Endothelial Cells via Endoglin/Smad1 Signaling. International Journal of Molecular Sciences 23:7, pages 3889.
Crossref
Lan Li, Liping Zhong, Chao Tang, Lu Gan, Tong Mo, Jintong Na, Jian He & Yong Huang. (2022) CD105: tumor diagnosis, prognostic marker and future tumor therapeutic target. Clinical and Translational Oncology 24:8, pages 1447-1458.
Crossref
Blanca Ayuso-Íñigo, Lucía Méndez-García, Miguel Pericacho & José M. Muñoz-Félix. (2021) The Dual Effect of the BMP9–ALK1 Pathway in Blood Vessels: An Opportunity for Cancer Therapy Improvement?. Cancers 13:21, pages 5412.
Crossref
Piotr K. Zakrzewski. (2021) Canonical TGFβ Signaling and Its Contribution to Endometrial Cancer Development and Progression—Underestimated Target of Anticancer Strategies. Journal of Clinical Medicine 10:17, pages 3900.
Crossref
Claudia Ollauri-Ibáñez, Blanca Ayuso-Íñigo & Miguel Pericacho. (2021) Hot and Cold Tumors: Is Endoglin (CD105) a Potential Target for Vessel Normalization?. Cancers 13:7, pages 1552.
Crossref
Teresa González Muñoz, Ana Teresa Amaral, Pilar Puerto-Camacho, Héctor Peinado & Enrique de Álava. (2021) Endoglin in the Spotlight to Treat Cancer. International Journal of Molecular Sciences 22:6, pages 3186.
Crossref
Yingmiao Liu, Madelon Paauwe, Andrew B. Nixon & Lukas J.A.C. Hawinkels. (2020) Endoglin Targeting: Lessons Learned and Questions That Remain. International Journal of Molecular Sciences 22:1, pages 147.
Crossref
Ana Nogués, Eunate Gallardo-Vara, Mª. Paz Zafra, Paloma Mate, Jose Luis Marijuan, Alfredo Alonso, Luisa Mª. Botella & Mª. Isabel Prieto. (2020) Endoglin (CD105) and VEGF as potential angiogenic and dissemination markers for colorectal cancer. World Journal of Surgical Oncology 18:1.
Crossref
Zhuoran Ma, Feifei Wang, Yeteng Zhong, Felix Salazar, Jiachen Li, Mingxi Zhang, Fuqiang Ren, Anna M. Wu & Hongjie Dai. (2020) Cross‐Link‐Functionalized Nanoparticles for Rapid Excretion in Nanotheranostic Applications. Angewandte Chemie International Edition 59:46, pages 20552-20560.
Crossref
Zhuoran Ma, Feifei Wang, Yeteng Zhong, Felix Salazar, Jiachen Li, Mingxi Zhang, Fuqiang Ren, Anna M. Wu & Hongjie Dai. (2020) Cross‐Link‐Functionalized Nanoparticles for Rapid Excretion in Nanotheranostic Applications. Angewandte Chemie 132:46, pages 20733-20741.
Crossref
Gallardo-Vara, Ruiz-Llorente, Casado-Vela, Ruiz-Rodríguez, López-Andrés, Pattnaik, Quintanilla & Bernabeu. (2019) Endoglin Protein Interactome Profiling Identifies TRIM21 and Galectin-3 as New Binding Partners. Cells 8:9, pages 1082.
Crossref
M. P. Samoilovich, A. A. Pinevich, N. L. Vartanyan, I. V. Smirnov, I. Yu. Krutetskaya, A. Yu. Stolbovaya, O. A. Shashkova, I. V. Gryazeva, M. A. Berlina, T. D. Smirnova & V. B. Klimovich. (2018) Endoglin Expression in Non-tumor and Tumor Cells of Different Origin. Cell and Tissue Biology 12:6, pages 437-447.
Crossref
Cheng Liu, Fei Yan, Yajie Xu, Hairong Zheng & Lei Sun. (2018) I n V ivo Molecular Ultrasound Assessment of Glioblastoma Neovasculature with Endoglin-Targeted Microbubbles . Contrast Media & Molecular Imaging 2018, pages 1-10.
Crossref
Sixiang Shi, Feng Chen, Shreya Goel, Stephen A. Graves, Haiming Luo, Charles P. Theuer, Jonathan W. Engle & Weibo Cai. (2018) In Vivo Tumor-Targeted Dual-Modality PET/Optical Imaging with a Yolk/Shell-Structured Silica Nanosystem. Nano-Micro Letters 10:4.
Crossref
Chuannan Fan, Jing Zhang, Wan Hua & Peter ten Dijke. 2018. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Selcuk Colak & Peter ten Dijke. (2017) Targeting TGF-β Signaling in Cancer. Trends in Cancer 3:1, pages 56-71.
Crossref
M Paauwe, R C Heijkants, C H Oudt, G W van Pelt, C Cui, C P Theuer, J C H Hardwick, C F M Sier & L J A C Hawinkels. (2016) Endoglin targeting inhibits tumor angiogenesis and metastatic spread in breast cancer. Oncogene 35:31, pages 4069-4079.
Crossref
Xiangyi Kong, Yu Wang, Shuai Liu, Bing Xing, Yi Yang, Yongning Li, Zuyuan Ren, Changbao Su, Wenbin Ma & Renzhi Wang. (2016) CD105 Over-expression Is Associated with Higher WHO Grades for Gliomas. Molecular Neurobiology 53:5, pages 3503-3512.
Crossref
Amaya García de Vinuesa, Salim Abdelilah-Seyfried, Petra Knaus, An Zwijsen & Sabine Bailly. (2016) BMP signaling in vascular biology and dysfunction. Cytokine & Growth Factor Reviews 27, pages 65-79.
Crossref
Chang-Han Chen, Hui-Ching Chuang, Yu-Tsai Lin, Fu-Min Fang, Chao-Cheng Huang, Ching-Mei Chen, Hui Lu & Chih-Yen Chien. (2015) Circulating CD105 shows significant impact in patients of oral cancer and promotes malignancy of cancer cells via CCL20. Tumor Biology 37:2, pages 1995-2005.
Crossref
Martin C. BoonstraSusanna W.L. De GeusHendrica A.J.M. PrevooLukas J.A.C. HawinkelsCornells J.H. Van De VeldePeter J.K. KuppenAlexander L. VahrmeijerCornelis F.M. Sier. (2016) Selecting Targets for Tumor Imaging: An Overview of Cancer-Associated Membrane Proteins. Biomarkers in Cancer 8, pages BIC.S38542.
Crossref
Tanja Dolinsek, Gregor Sersa, Lara Prosen, Masa Bosnjak, Monika Stimac, Urska Razborsek & Maja Cemazar. (2015) Electrotransfer of Plasmid DNA Encoding an Anti-Mouse Endoglin (CD105) shRNA to B16 Melanoma Tumors with Low and High Metastatic Potential Results in Pronounced Anti-Tumor Effects. Cancers 8:1, pages 3.
Crossref
Stephanie C. Casey, Amedeo Amedei, Katia Aquilano, Asfar S. Azmi, Fabian Benencia, Dipita Bhakta, Alan E. Bilsland, Chandra S. Boosani, Sophie Chen, Maria Rosa Ciriolo, Sarah Crawford, Hiromasa Fujii, Alexandros G. Georgakilas, Gunjan Guha, Dorota Halicka, William G. Helferich, Petr Heneberg, Kanya Honoki, W. Nicol Keith, Sid P. Kerkar, Sulma I. Mohammed, Elena Niccolai, Somaira Nowsheen, H.P. Vasantha Rupasinghe, Abbas Samadi, Neetu Singh, Wamidh H. Talib, Vasundara Venkateswaran, Richard L. Whelan, Xujuan Yang & Dean W. Felsher. (2015) Cancer prevention and therapy through the modulation of the tumor microenvironment. Seminars in Cancer Biology 35, pages S199-S223.
Crossref
J. M. Denbeigh, B. A. Nixon, J. J. Y. Lee, M. Jerkic, P. A. Marsden, M. Letarte, M. C. Puri & F. S. Foster. (2014) Contrast-enhanced molecular ultrasound differentiates endoglin genotypes in mouse embryos. Angiogenesis 18:1, pages 69-81.
Crossref
Xiao Huang, Caixia Yi, Yijuan Fan, Yinxing Zhang, Limei Zhao, Zhiqing Liang & Jun Pan. (2014) Magnetic Fe3O4 nanoparticles grafted with single-chain antibody (scFv) and docetaxel loaded β-cyclodextrin potential for ovarian cancer dual-targeting therapy. Materials Science and Engineering: C 42, pages 325-332.
Crossref
Valeria Barresi, Giovanni Branca, Maria Caffo, Rosario Caltabiano, Antonio Ieni, Enrica Vitarelli, Salvatore Lanzafame & Giovanni Tuccari. (2014) Immuno-Expression of Endoglin and Smooth Muscle Actin in the Vessels of Brain Metastases. Is There a Rational for Anti-Angiogenic Therapy?. International Journal of Molecular Sciences 15:4, pages 5663-5679.
Crossref
Leon Jonker. (2014) TGF- β & BMP Receptors Endoglin and ALK1: Overview of their Functional Role and Status as Antiangiogenic Targets . Microcirculation 21:2, pages 93-103.
Crossref
Lee S. Rosen, Michael S. Gordon, Francisco Robert & Daniela E. Matei. (2014) Endoglin for Targeted Cancer Treatment. Current Oncology Reports 16:2.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.